PriceTargets.com logo

GoHealth - GOCO Stock Price Target and Predictions

  • Consensus Rating: Hold
  • Consensus Price Target: $13.00
  • Forecasted Upside: 1.72%
  • Number of Analysts: 1
  • Breakdown:
  • 0 Sell Ratings
  • 1 Hold Ratings
  • 0 Buy Ratings
  • 0 Strong Buy Ratings
$12.78 As of 12/20/2024 06:16 PM ET
▲ +0.1 (0.79%)

This chart shows the closing price for GOCO by one month, three months, or twelve months.

Skip Closing Price Chart
1 month | 3 months | 12 months
Get New GoHealth Analyst Ratings Delivered To Your Inbox
Sign-up to receive the latest news and ratings for GOCO and its competitors with Analyst Ratings Network’s free daily newsletter.

Analyst Price Target for GOCO

Analyst Price Target is $13.00
▲ +1.72% Upside Potential
This price target is based on 1 analysts offering 12 month price targets for GoHealth in the last 3 months. The average price target is $13.00, with a high forecast of $13.00 and a low forecast of $13.00. The average price target represents a 1.72% upside from the last price of $12.78.

This chart shows the closing price for GOCO for the last year in relation to the current analyst high, average, and low pricetarget.

Read Analyst Price Chart DescriptionSkip Analyst Price Chart




Current Consensus is Hold

The current consensus among 1 contributing investment analysts is to hold stock in GoHealth. This rating has held steady since March 2024, when it changed from a Reduce consensus rating.

Past Monthly Recommendations

Move your mouse over past months for details

Read Past Recommendations DescriptionSkip Past Price Target Consensus Chart
  • 0 strong buy ratings
  • 0 buy ratings
  • 1 hold ratings
  • 1 sell ratings
Ratings as of
6/29/2023
  • 0 strong buy ratings
  • 0 buy ratings
  • 1 hold ratings
  • 1 sell ratings
Ratings as of
9/27/2023
  • 0 strong buy ratings
  • 0 buy ratings
  • 1 hold ratings
  • 1 sell ratings
Ratings as of
12/26/2023
  • 0 strong buy ratings
  • 0 buy ratings
  • 1 hold ratings
  • 1 sell ratings
Ratings as of
3/25/2024
  • 0 strong buy ratings
  • 0 buy ratings
  • 1 hold ratings
  • 0 sell ratings
Ratings as of
6/23/2024
  • 0 strong buy ratings
  • 0 buy ratings
  • 1 hold ratings
  • 0 sell ratings
Ratings as of
9/21/2024
  • 0 strong buy ratings
  • 0 buy ratings
  • 1 hold ratings
  • 0 sell ratings
Ratings as of
11/20/2024
  • 0 strong buy ratings
  • 0 buy ratings
  • 1 hold ratings
  • 0 sell ratings
Ratings as of
12/20/2024

Latest Recommendations

  • 0 strong buy ratings
  • 0 buy ratings
  • 1 hold ratings
  • 0 sell ratings

Display Ratings By
DateBrokerageActionRatingPrice TargetDetails
10/21/2024Royal Bank of CanadaReiterated RatingSector Perform ➝ Sector Perform$13.00 ➝ $13.00
3/20/2024Royal Bank of CanadaLower TargetSector Perform ➝ Sector Perform$20.00 ➝ $13.00
4/4/2023Credit Suisse GroupBoost TargetUnderperform$7.00 ➝ $8.50
3/17/2023Bank of AmericaBoost Target$9.75 ➝ $11.00
3/17/2023Royal Bank of CanadaLower TargetSector Perform$15.00 ➝ $14.00
11/24/2022Credit Suisse GroupSet Target$7.00
8/16/2022Credit Suisse GroupLower TargetUnderperform$1.50 ➝ $1.25
3/17/2022Credit Suisse GroupLower Target$3.00 ➝ $1.50
3/16/2022Evercore ISILower TargetIn-Line$4.50 ➝ $1.75
3/3/2022Royal Bank of CanadaDowngradeOutperform ➝ Sector Perform$10.00 ➝ $2.00
3/2/2022Truist FinancialDowngradeBuy ➝ Hold$2.00
1/7/2022Credit Suisse GroupDowngradeNeutral ➝ Underperform$6.00 ➝ $3.00
1/5/2022Bank of AmericaDowngradeBuy ➝ Underperform$7.50 ➝ $3.50
11/15/2021Credit Suisse GroupLower TargetNeutral$7.00 ➝ $6.00
11/11/2021Morgan StanleyLower TargetEqual Weight$13.00 ➝ $5.50
11/10/2021Royal Bank of CanadaLower TargetOutperform$17.00 ➝ $10.00
11/9/2021BarclaysDowngradeOverweight ➝ Equal Weight$10.00 ➝ $5.00
8/13/2021BarclaysLower TargetOverweight$18.00 ➝ $10.00
8/12/2021Cantor FitzgeraldReiterated RatingOverweight
8/12/2021Morgan StanleyLower TargetEqual Weight$14.00 ➝ $13.00
8/12/2021Credit Suisse GroupDowngradeOutperform ➝ Neutral$18.00 ➝ $10.00
8/12/2021Raymond JamesDowngradeOutperform ➝ Market Perform
5/17/2021Raymond JamesLower TargetOutperform$15.00 ➝ $14.00
5/17/2021Credit Suisse GroupLower TargetOutperform$19.00 ➝ $18.00
5/14/2021Morgan StanleyBoost TargetEqual Weight$13.00 ➝ $14.00
5/13/2021Truist FinancialLower TargetBuy ➝ Buy$26.00 ➝ $20.00
3/15/2021Raymond JamesLower TargetOutperform$18.00 ➝ $15.00
3/10/2021Morgan StanleyLower TargetEqual Weight$14.00 ➝ $13.00
3/9/2021Credit Suisse GroupLower TargetOutperform$21.00 ➝ $19.00
11/16/2020Credit Suisse GroupLower TargetOutperform$25.00 ➝ $21.00
11/12/2020Evercore ISILower TargetOutperform$27.00 ➝ $25.00
11/12/2020Raymond JamesReiterated RatingBuy
11/12/2020Morgan StanleyLower TargetEqual Weight$18.00 ➝ $14.00
10/2/2020Raymond JamesInitiated CoverageOutperform$18.00 ➝ $18.00
8/20/2020Credit Suisse GroupReiterated RatingBuy$25.00
8/20/2020Morgan StanleyBoost TargetEqual Weight$17.00 ➝ $18.00
8/11/2020William BlairInitiated CoverageOutperform
8/10/2020Royal Bank of CanadaInitiated CoverageOutperform$22.00
8/10/2020Truist FinancialInitiated CoverageBuy
8/10/2020Bank of AmericaInitiated CoverageBuy$22.00
8/10/2020Cantor FitzgeraldInitiated CoverageOverweight$26.00
8/10/2020Credit Suisse GroupInitiated CoverageOutperform$25.00
8/10/2020Morgan StanleyInitiated CoverageEqual Weight$17.00
8/10/2020BarclaysInitiated CoverageOverweight$22.00
8/10/2020The Goldman Sachs GroupInitiated CoverageBuy$21.00
8/9/2020Evercore ISIInitiated CoverageOutperform$27.00
(Data available from 12/21/2019 forward)

News Sentiment Rating

0.64 (Buy)

Our news sentiment rating is based on the average sentiment of articles about this company published in the media in the last 30 days of headlines and can range from 2 (very positive sentiment) to -2 (very negative sentiment).

News Sentiment Over Time

Move your mouse over past months for details

Skip to Current Sentiment Summary
  • 0 very positive mentions
  • 6 positive mentions
  • 1 negative mentions
  • 1 very negative mentions
Mentions as of
5/25/2024
  • 1 very positive mentions
  • 3 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
Mentions as of
6/24/2024
  • 0 very positive mentions
  • 1 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
Mentions as of
7/24/2024
  • 0 very positive mentions
  • 6 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
Mentions as of
8/23/2024
  • 2 very positive mentions
  • 3 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
Mentions as of
9/22/2024
  • 1 very positive mentions
  • 6 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
Mentions as of
10/22/2024
  • 3 very positive mentions
  • 9 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
Mentions as of
11/21/2024
  • 1 very positive mentions
  • 2 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
Mentions as of
12/21/2024

Current Sentiment

  • 1 very positive mentions
  • 2 positive mentions
  • 0 negative mentions
  • 0 very negative mentions

Recent Stories by Sentiment

Very Negative

  • No very negative mentions tracked during this time.

Negative

  • No negative mentions tracked during this time.

Positive

Very Positive

GoHealth logo
GoHealth, Inc. operates as a health insurance marketplace and Medicare-focused digital health company in the United States. The company operates a technology platform that leverages machine-learning algorithms of insurance behavioral data to optimize the process for helping individuals find the health insurance plan for their specific needs. It provides Medicare plans, including Medicare Advantage, Medicare Supplement and Prescription Drug, and Medicare Special Needs Plans. The company also offers partner marketing services. It sells its products through carriers and online platform, as well as independent and external agencies. The company was founded in 2001 and is headquartered in Chicago, Illinois.
Read More

Today's Range

Now: $12.78
Low: $12.48
High: $13.09

50 Day Range

MA: $11.55
Low: $8.98
High: $13.36

52 Week Range

Now: $12.78
Low: $7.27
High: $16.44

Volume

71,595 shs

Average Volume

21,646 shs

Market Capitalization

$292.74 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

1.69

Frequently Asked Questions

What sell-side analysts currently cover shares of GoHealth?

The following sell-side analysts have issued research reports on GoHealth in the last twelve months: Royal Bank of Canada.
View the latest analyst ratings for GOCO.

What is the current price target for GoHealth?

0 Wall Street analysts have set twelve-month price targets for GoHealth in the last year. Their average twelve-month price target is $13.00, suggesting a possible upside of 1.7%. Royal Bank of Canada has the highest price target set, predicting GOCO will reach $13.00 in the next twelve months. Royal Bank of Canada has the lowest price target set, forecasting a price of $13.00 for GoHealth in the next year.
View the latest price targets for GOCO.

What is the current consensus analyst rating for GoHealth?

GoHealth currently has 1 hold rating from Wall Street analysts. The stock has a consensus analyst rating of "Hold." A "hold" rating indicates that analysts believe investors should keep any existing positions they have in GOCO, but not buy more shares or sell existing shares.
View the latest ratings for GOCO.

What other companies compete with GoHealth?

Other companies that are similar to GoHealth include Tiptree, Hippo, Ambac Financial Group, SelectQuote and TWFG. Learn More about companies similar to GoHealth.

How do I contact GoHealth's investor relations team?

GoHealth's physical mailing address is 214 WEST HURON STREET, CHICAGO IL, 60654. The company's listed phone number is 312-386-8200 and its investor relations email address is [email protected]. The official website for GoHealth is www.gohealth.com. Learn More about contacing GoHealth investor relations.